암젠 주식회사
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionKeel Point, LLC
Latest Disclosed Ownership2,607 shares
Latest Disclosed Value $ 917,194
Keel Point, LLC reports 28.18% decrease in ownership of AMGN / Amgen Inc.

On May 29, 2026 - Keel Point, LLC filed a 13F-HR form disclosing ownership of 2,607 shares of Amgen Inc. (MX:AMGN) valued at $917,194 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 3,630 shares of Amgen Inc.. This represents a change in shares of -28.18% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-29 2026-03-31 13F AMGEN COM 031162100 2,607 -1,023 -28.18 917 -22.81 0.0594
2026-02-12 2025-12-31 13F AMGEN COM 031162100 3,630 2 0.06 1,188 16.13 0.0716
2025-12-16 2025-09-30 13F AMGEN COM 031162100 3,628 -147 -3.89 1,024 -2.94 0.0630
2025-08-15 2025-06-30 13F AMGEN COM 031162100 3,775 735 24.18 1,054 11.30 0.0697
2025-05-15 2025-03-31 13F AMGEN COM 031162100 3,040 575 23.33 947 47.51 0.0735
2025-02-14 2024-12-31 13F AMGEN COM 031162100 2,465 -190 -7.16 643 -24.91 0.0514
2024-11-14 2024-09-30 13F AMGEN COM 031162100 2,655 -65 -2.39 856 -2.73 0.0713
2024-08-14 2024-06-30 13F AMGEN COM 031162100 2,720 556 25.69 880 42.93 0.0794
2024-04-16 2024-03-31 13F AMGEN COM 031162100 2,164 41 1.93 615 0.65 0.0636
2024-01-30 2023-12-31 13F AMGEN COM 031162100 2,123 107 5.31 611 12.94 0.0730
2023-10-26 2023-09-30 13F AMGEN COM 031162100 2,016 134 7.12 542 29.74 0.0743
2023-07-12 2023-06-30 13F AMGEN COM 031162100 1,882 248 15.18 418 5.57 0.0558
2023-04-03 2023-03-31 13F AMGEN COM 031162100 1,634 -43 -2.56 395 -10.23 0.0571
2023-01-17 2022-12-31 13F AMGEN COM 031162100 1,677 203 13.77 440 32.53 0.0691
2022-10-05 2022-09-30 13F AMGEN COM 031162100 1,474 22 1.52 332 -9.29 0.0569
2022-08-11 2022-06-30 13F AMGEN COM 031162100 1,452 68 4.91 366 9.25 0.0570
2022-04-27 2022-03-31 13F AMGEN COM 031162100 1,384 103 8.04 335 16.32 0.0502
2022-01-31 2021-12-31 13F AMGEN COM 031162100 1,281 35 2.81 288 8.68 0.0323
2021-11-04 2021-09-30 13F AMGEN COM 031162100 1,246 15 1.22 265 -11.67 0.0343
2021-08-06 2021-06-30 13F/A-1 AMGEN COM 031162100 1,231 -6 -0.49 300 -2.60 0.0334
2021-08-06 2021-06-30 13F AMGEN COM 031162100 1 -1,236 552 0.1281
2021-05-17 2021-03-31 13F AMGEN COM 031162100 1,237 1,237 0.49 308 2.67 0.0300
2019-05-14 2019-03-31 13F Amgen COM 031162100 0 -3,755 -100.00 0 -100.00
2019-02-08 2018-12-31 13F Amgen COM 031162100 3,755 27 0.72 731 -5.43 0.0990
2018-11-07 2018-09-30 13F Amgen COM 031162100 3,728 44 1.19 773 13.68 0.0960
2018-08-13 2018-06-30 13F Amgen COM 031162100 3,684 324 9.64 680 18.67 0.0905
2018-05-07 2018-03-31 13F Amgen COM 031162100 3,360 100 3.07 573 1.06 0.0784
2018-02-08 2017-12-31 13F Amgen COM 031162100 3,260 1 0.03 567 -6.74 0.0784
2017-11-09 2017-09-30 13F Amgen COM 031162100 3,259 -250 -7.12 608 0.66 0.0926
2017-08-15 2017-06-30 13F Amgen COM 031162100 3,509 43 1.24 604 6.15 0.1213
2017-05-15 2017-03-31 13F Amgen COM 031162100 3,466 0 0.00 569 12.23 0.1149
2017-02-15 2016-12-31 13F Amgen COM 031162100 3,466 -31 -0.89 507 -13.04 0.1139
2016-11-15 2016-09-30 13F Amgen COM 031162100 3,497 331 10.45 583 20.95 0.2214
2016-07-12 2016-06-30 13F Amgen COM 031162100 3,166 0 0.00 482 1.47 0.2076
2016-05-13 2016-03-31 13F/A-1 Amgen COM 031162100 3,166 0 0.00 475 -7.59 0.2393
2016-05-13 2016-03-31 13F Amgen COM 031162100 3,166 475
2016-02-04 2015-12-31 13F Amgen COM 031162100 3,166 0 0.00 514 17.35 0.2778
2015-11-04 2015-09-30 13F Amgen COM 031162100 3,166 0 0.00 438 -13.95 0.2449
2015-07-31 2015-06-30 13F Amgen COM 031162100 3,166 0 0.00 509 0.59 0.2426
2015-05-14 2015-03-31 13F Amgen COM 031162100 3,166 3,166 506 0.2537
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.